A bispecific CD47/CD19 antibody harnesses the phagocytic potential of tumor-associated macrophages (TAMs) and remodels the tumor microenvironment to effectively control B-cell lymphoma growth in mice

Explore related products in the following collection:

Poster Abstracts - C717

ePosters - C717

Related Products

Thumbnail for Beyond Immune Checkpoint: First-in-Class antibody targeting soluble NKG2D ligand sMIC for cancer immunotherapy

Beyond Immune Checkpoint: First-in-Class antibody targeting soluble NKG2D ligand sMIC for cancer immunotherapy

Thumbnail for Cathepsin D inhibitors as potential therapeutics for breast cancer treatment against triple-negative and triple-positive breast cancers

Cathepsin D inhibitors as potential therapeutics for breast cancer treatment against triple-negative and triple-positive breast cancers

Thumbnail for Blimp-1+ regulatory T cells are associated with longer disease-free survival in colorectal cancer

Blimp-1+ regulatory T cells are associated with longer disease-free survival in colorectal cancer

Thumbnail for In Vitro Anticancer Activity of Polysaccharide and Protein Fractions from Pithecellobium jiringa

In Vitro Anticancer Activity of Polysaccharide and Protein Fractions from Pithecellobium jiringa

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.